| Literature DB >> 33858813 |
Markus Grabbert1, August Sigle2, Larissa Lang2, Moritz von Büren2, Michael Mix3, Constantinos Zamboglou4, Christian Gratzke2, Wolfgang Schultze-Seemann2, Cordula A Jilg2.
Abstract
This case series highlights the role of repeat salvage lymph node dissection (sLND) for nodal-recurrent prostate cancer. We provide a descriptive analysis of ten patients who underwent sLND in a total of 23 surgeries (mean 2.3 sLNDs per patient) and their long-term follow-up (median of 158 mo after radical prostatectomy). A complete prostate-specific antigen response was observed in nine/23 cases (39.1%), and an incomplete response in 14 (60.9%). Analysis by anatomical location revealed a trend towards more distant metastases on repeat surgery, with only three in-field recurrences in patients with previously positive nodes. Repeat sLND can be surgically challenging, and major intraoperative complications were observed in three/23 cases (13.0%). Repeat sLND for patients with nodal-recurrent prostate cancer seems to be a feasible treatment option, albeit only in carefully selected patients. Nevertheless, it remains a highly experimental approach with unclear oncological benefit.Entities:
Keywords: Nodal-recurrent prostate cancer; Oncological outcome; Salvage lymph node dissection
Mesh:
Year: 2021 PMID: 33858813 DOI: 10.1016/j.euf.2021.03.025
Source DB: PubMed Journal: Eur Urol Focus ISSN: 2405-4569